These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 22898910

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL, Huang CY, Huang YS, Chen RJ, Wang CW, Chen YH, Cheng JC, Cheng AL, Kuo SH.
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
    Li X, Wei LC, Zhang Y, Zhao LN, Li WW, Ping LJ, Dang YZ, Hu J, Shi M.
    Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
    [Abstract] [Full Text] [Related]

  • 25. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
    Chaney AW, Eifel PJ, Logsdon MD, Morris M, Wharton JT.
    Int J Radiat Oncol Biol Phys; 1999 Aug 01; 45(1):113-8. PubMed ID: 10477014
    [Abstract] [Full Text] [Related]

  • 26. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 01; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 27. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S, Isohashi F, Okazawa M, Kitada F, Maruoka S, Ogawa K, Kimura T.
    J Gynecol Oncol; 2017 Jan 01; 28(1):e15. PubMed ID: 27958682
    [Abstract] [Full Text] [Related]

  • 28. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
    Wang JQ, Wang T, Shi F, Yang YY, Su J, Chai YL, Liu Z.
    Asian Pac J Cancer Prev; 2015 Jan 01; 16(14):5957-61. PubMed ID: 26320479
    [Abstract] [Full Text] [Related]

  • 29. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
    Hashmi H, Maqbool A, Ahmed S, Ahmed A, Sheikh K, Ahmed A.
    J Coll Physicians Surg Pak; 2016 Apr 01; 26(4):302-5. PubMed ID: 27097702
    [Abstract] [Full Text] [Related]

  • 30. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan 01; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 31. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
    Umayahara K, Takekuma M, Hirashima Y, Noda SE, Ohno T, Miyagi E, Hirahara F, Hirata E, Kondo E, Tabata T, Nagai Y, Aoki Y, Wakatsuki M, Takeuchi M, Toita T, Takeshima N, Takizawa K.
    Gynecol Oncol; 2016 Feb 01; 140(2):253-8. PubMed ID: 26701414
    [Abstract] [Full Text] [Related]

  • 32. Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam.
    Phung HT, Truong MC, Nguyen LT, Dang ATV, Vu TH, Nguyen HT.
    Asian Pac J Cancer Prev; 2021 Mar 01; 22(3):853-859. PubMed ID: 33773550
    [Abstract] [Full Text] [Related]

  • 33. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC, Tung SY, Leung TW, Sze WK, Wong VY, Lui CM, Yuen KK, O SK.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1254-64. PubMed ID: 12654435
    [Abstract] [Full Text] [Related]

  • 34. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
    Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.
    Strahlenther Onkol; 2002 Jul 01; 178(7):378-85. PubMed ID: 12163992
    [Abstract] [Full Text] [Related]

  • 35. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO, Kim GE.
    Gynecol Oncol; 2007 Jan 01; 104(1):58-63. PubMed ID: 16919718
    [Abstract] [Full Text] [Related]

  • 36. Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma.
    Dracham CB, Mahajan R, Rai B, Elangovan A, Bhattacharya T, Ghoshal S.
    Jpn J Clin Oncol; 2019 Feb 01; 49(2):146-152. PubMed ID: 30452664
    [Abstract] [Full Text] [Related]

  • 37. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.
    Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB.
    Am J Clin Oncol; 2014 Feb 01; 37(1):57-62. PubMed ID: 23357967
    [Abstract] [Full Text] [Related]

  • 38. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE.
    Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):351-8. PubMed ID: 10030261
    [Abstract] [Full Text] [Related]

  • 39. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e49-56. PubMed ID: 21470794
    [Abstract] [Full Text] [Related]

  • 40. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.
    King M, McConkey C, Latief TN, Hartley A, Fernando I.
    Clin Oncol (R Coll Radiol); 2006 Feb 01; 18(1):38-45. PubMed ID: 16477918
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.